Nutrition 21 gains license for ProBiomega
PURCHASE, N.Y. Nutrition 21 on Friday announced that the company has obtained an exclusive license for a patented combination of a probiotic and omega-3 fish oil from ProbioHealth and ProbioFerm.
“The probiotic included in the exclusive license, Lactobacillus casei ATCC 3945, has shown enhanced stability when mixed with omega-3 fish oil,” stated James Komorowski, VP R&D at Nutrition 21. “The omega-3 fish oil coats the probiotic and provides a beneficial barrier to air and moisture,” he said. “So not only will consumers obtain the digestive health and heart health benefit from the probiotic and omega-3 fish oil, but the combination also enhances the shelf life of the finished product.”
“This new product, called ProBiomega, is the only product available that combines the benefits of a probiotic and omega-3 fish oil,” added Michael Zeher, Nutrition 21 president and CEO. “We are very excited to enter the fast-growing probiotic market with this unique product formulation.”
Donnenfeld joins Advanced Vision Research
WOBURN, Mass. Advanced Vision Research named Eric Donnenfeld to the post of chief medical officer.
“Donnenfeld is one of the pre-eminent ophthalmologists practicing today with a broad scope of experience and knowledge,” stated Leigh Reynolds, Advanced Vision COO. “He is a key thought leader who will play a critical role for Advanced Vision Research as we move forward with new product research and development,” he said.
Donnenfeld has been a leader in ophthalmology for more than 20 years, the eye-care company stated. He is on the editorial board of nine medical journals, and is one of the authors of the American Academy of Ophthalmology’s Refractive Surgery Basic Science Book. Donnenfeld graduated with honors at the top of his class at Dartmouth Medical School. He was chief resident at Manhattan Eye Ear and Throat Hospital and he completed his Cornea and Refractive Fellowship at Wills Eye Hospital in Philadelphia.
Bodybuilding.com heeds FDA recall of dietary supplements
BOISE, Idaho Bodybuilding.com on Tuesday announced that it is conducting a voluntary nationwide and international recall of all lots and expiration dates of 65 dietary supplement products that were sold through the company’s Web site, www.bodybuilding.com, after learning from the Food and Drug Administration that the recalled products may contain steroids.
Specifically, the FDA has advised Bodybuilding.com of the agency’s concern that the recalled products may contain the following ingredients that are currently classified, or the FDA believes should be classified, as steroids: “Superdrol,” “Madol,” “Tren,” “Androstenedione,” and/or “Turinabol.”
Bodybuilding.com claimed it had not had an opportunity to independently confirm the FDA’s concerns that the products in fact contain these ingredients, but was initiating the recall in “an abundance of caution.”